A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
Doebele, R.C., Conkling, P., Traynor, A.M., Otterson, G.A., Zhao, Y., Wind, S., Stopfer, P., Kaiser, R., Camidge, D.R.
Published in Annals of oncology (01.08.2012)
Published in Annals of oncology (01.08.2012)
Get full text
Journal Article
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
Dasari, A., Gore, L., Messersmith, W. A., Diab, S., Jimeno, A., Weekes, C. D., Lewis, K. D., Drabkin, H. A., Flaig, T. W., Camidge, D. R.
Published in Investigational new drugs (01.02.2013)
Published in Investigational new drugs (01.02.2013)
Get full text
Journal Article
A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer
Besse, B., Heist, R.S., Papadmitrakopoulou, V.A., Camidge, D.R., Beck, J.T., Schmid, P., Mulatero, C., Miller, N., Dimitrijevic, S., Urva, S., Pylvaenaeinen, I., Petrovic, K., Johnson, B.E.
Published in Annals of oncology (01.02.2014)
Published in Annals of oncology (01.02.2014)
Get full text
Journal Article
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC
Peters, T. L., Patil, T., Le, A. T., Davies, K. D., Brzeskiewicz, P. M., Nijmeh, H., Bao, L., Camidge, D. R., Aisner, D. L., Doebele, R. C.
Published in NPJ precision oncology (12.10.2021)
Published in NPJ precision oncology (12.10.2021)
Get full text
Journal Article
The epidemiology of self‐poisoning in the UK
Camidge, D. R., Wood, R. J., Bateman, D. N.
Published in British journal of clinical pharmacology (01.12.2003)
Published in British journal of clinical pharmacology (01.12.2003)
Get full text
Journal Article
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
Mok, T., Camidge, D.R., Gadgeel, S.M., Rosell, R., Dziadziuszko, R., Kim, D.-W., Pérol, M., Ou, S.-H.I., Ahn, J.S., Shaw, A.T., Bordogna, W., Smoljanović, V., Hilton, M., Ruf, T., Noé, J., Peters, S.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Mazieres, J., Drilon, A., Lusque, A., Mhanna, L., Cortot, A.B., Mezquita, L., Thai, A.A., Mascaux, C., Couraud, S., Veillon, R., Van den Heuvel, M., Neal, J., Peled, N., Früh, M., Ng, T.L., Gounant, V., Popat, S., Diebold, J., Sabari, J., Zhu, V.W., Rothschild, S.I., Bironzo, P., Martinez-Marti, A., Curioni-Fontecedro, A., Rosell, R., Lattuca-Truc, M., Wiesweg, M., Besse, B., Solomon, B., Barlesi, F., Schouten, R.D., Wakelee, H., Camidge, D.R., Zalcman, G., Novello, S., Ou, S.I., Milia, J., Gautschi, O.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Shaw, A.T., Riely, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Solomon, B.J., Varella-Garcia, M., Iafrate, A.J., Shapiro, G.I., Usari, T., Wang, S.C., Wilner, K.D., Clark, J.W., Ou, S.-H.I.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study
Gadgeel, S., Peters, S., Mok, T., Shaw, A.T., Kim, D.W., Ou, S.I., Pérol, M., Wrona, A., Novello, S., Rosell, R., Zeaiter, A., Liu, T., Nüesch, E., Balas, B., Camidge, D.R.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors
Kris, M.G., Camidge, D.R., Giaccone, G., Hida, T., Li, B.T., O'Connell, J., Taylor, I., Zhang, H., Arcila, M.E., Goldberg, Z., Jänne, P.A.
Published in Annals of oncology (01.07.2015)
Published in Annals of oncology (01.07.2015)
Get full text
Journal Article
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Felip, E., Shaw, A.T., Bearz, A., Camidge, D.R., Solomon, B.J., Bauman, J.R., Bauer, T.M., Peters, S., Toffalorio, F., Abbattista, A., Thurm, H., Peltz, G., Wiltshire, R., Besse, B.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
Wang, Y., Jiang, T., Qin, Z., Jiang, J., Wang, Q., Yang, S., Rivard, C., Gao, G., Ng, T.L., Tu, M.M., Yu, H., Ji, H., Zhou, C., Ren, S., Zhang, J., Bunn, P., Doebele, R.C., Camidge, D.R., Hirsch, F.R.
Published in Annals of oncology (01.03.2019)
Published in Annals of oncology (01.03.2019)
Get full text
Journal Article
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
Krug, A.K., Enderle, D., Karlovich, C., Priewasser, T., Bentink, S., Spiel, A., Brinkmann, K., Emenegger, J., Grimm, D.G., Castellanos-Rizaldos, E., Goldman, J.W., Sequist, L.V., Soria, J.-C., Camidge, D.R., Gadgeel, S.M., Wakelee, H.A., Raponi, M., Noerholm, M., Skog, J.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK
CAMIDGE, D. R, STOCKTON, D. L, FRAME, S, WOOD, R, BAIN, M, BATEMAN, D. N
Published in British journal of cancer (12.03.2007)
Published in British journal of cancer (12.03.2007)
Get full text
Journal Article
A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors
Leong, S., Eckhardt, S. G., Chan, E., Messersmith, W. A., Spratlin, J., Camidge, D. R., Diab, S., Khosravan, R., Lin, X., Chow Maneval, E., Lockhart, A. C.
Published in Cancer chemotherapy and pharmacology (01.07.2012)
Published in Cancer chemotherapy and pharmacology (01.07.2012)
Get full text
Journal Article